Riding high: Increased research and development has benefited the industry

The Brand-Name and Generic Pharmaceutical Manufacturing industry in Ontario experienced strong growth over the past five years, due to the province's comprehensive support for research and development efforts. Ontario is recognized as the province leading the pharmaceutical industry in Canada, with its notable passing of Bill 102, the Transparent Drug System for Patients Act, 2006 and regularly updated Ontario Drug Benefit Formulary/Comparative Drug Index, both reducing the generic drug pricing. With Ontario being the main hub for pharmaceutical manufacturers, the province's industry revenue is projected to grow over the five years to 2018...read more.

Industry Statistics & Market Size
Revenue
$8bn
Annual Growth 13-18
6.3%
Forecast Growth 18-23
Profit
Employment
17,718
Businesses
226

Industry Threats & Opportunities

  • Ontario pioneered the pricing pressures between brand-name and generic drugs
  • Industry Report - Industry Locations Chapter

    Ontario comprises 40.8% of the national industry's establishment counts due to the province being the most populated. In addition, Ontario's credible hospitals, universities and institutes, on top of strong government assistance have attracted global pharmaceutical manufacturers to build production and research and development (R&D) facilities. Furthermore, facilities by the Great Lakes support the businesses in the area with access to imports and established networks of transportation. Trending with the broader manufacturing sector, the Toronto economic region is projected to represent more than 40.0% of manufacturing establishments and employees. The...purchase to read more.

    Additional Insights for the Brand-Name & Generic Pharmaceutical Manufacturing in Ontario Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Brand-Name & Generic Pharmaceutical Manufacturing in Ontario Industry are

  • Establishment of brand names
  • Undertaking technical research and development
  • Degree of globalization in the company
  • IBISWorld analysts also discuss how external factors such as Research and development expenditure and Total health expenditure in the Brand-Name & Generic Pharmaceutical Manufacturing in Ontario industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Brand-Name & Generic Pharmaceutical Manufacturing in Ontario Industry?

    This industry develops prescription and over-the-counter drug products used to treat illnesses in humans and animals. Brand-name drugs have patent protection, while generic drugs are produced and distributed without patent protection. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

    Industry Products
  • Nervous system/Cardiovascular
  • Antineoplastic/immunomodulating agents
  • Alimentary tract/metabolism
  • Respiratory system/sensory organs
  • Antiinfectives/ blood drugs
  • Musculoskeletal system
  • Genitourinary/hormones
  • Industry Activities
  • Pharmaceutical research and development
  • Manufacturing active ingredients used in pharmaceuticals
  • Manufacturing chemical pharmaceutical preparations
  • Manufacturing biological pharmaceutical products
  • Gaining regulatory approval for generic drugs
  • Developing and producing generic drugs
  • Marketing and distributing generic drugs
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Research and development expenditure
  • Total health expenditure
  • Number of Adults aged 65 and older in Ontario
  • Canadian-dollar effective exchange rate index

  • Current Performance
    Industry Outlook
    Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Brand-Name & Generic Pharmaceutical Manufacturing in Ontario Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Pharmaceuticals & Pharmacy Supplies Wholesaling in Canada
  • Supermarkets & Grocery Stores in Canada
  • Pharmacies & Drug Stores in Canada
  • Hospitals in Canada

  • Key Selling Industries
  • Brand-Name Pharmaceutical Manufacturing in Canada
  • Chemical Product Manufacturing in Canada
  • Generic Pharmaceutical Manufacturing in Canada
  • Medical Device Manufacturing in Canada
  • Medical Instrument & Supply Manufacturing in Canada
  • Navigational Instrument Manufacturing in Canada
  • Soap & Cleaning Compound Manufacturing in Canada

  • Products & Services
  • Nervous system/Cardiovascular
  • Antineoplastic/immunomodulating agents
  • Antiinfectives/ blood drugs
  • Respiratory system/sensory organs
  • Alimentary tract/metabolism
  • Other
  • Genitourinary/hormones
  • Musculoskeletal system
  • Chart: Brand-Name & Generic Pharmaceutical Manufacturing in Ontario Industry Products and Services Segmentation

  • Major Markets
  • Private insurers
  • Public sector
  • Households
  • Chart: Major Market Segmentation for the Brand-Name & Generic Pharmaceutical Manufacturing in Ontario Industry

  • Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Chart: Cost Structure Benchmarking – Sector vs Brand-Name & Generic Pharmaceutical Manufacturing in Ontario

  • Basis of Competition
    Barriers to Entry
    Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Apotex Inc.,
  • Table: Pfizer Inc. - financial performance
  • Table: Sanofi - financial performance
  • Table: Teva Pharmaceutical Industries Ltd. - financial performance
  • Table: Apotex Inc. - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Brand-Name & Generic Pharmaceutical Manufacturing in Ontario Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Brand-Name & Generic Pharmaceutical Manufacturing in Ontario Industry
    Includes:
  • Industry Revenue (2009-2023)
  • Industry Gross Product (2009-2023)
  • Establishments (2009-2023)
  • Businesses (2009-2023)
  • Employment (2009-2023)
  • Wages (2009-2023)
  • ON - Local and provincial government expenditure in Ontario (2009-2023)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Active Pharmaceutical Ingredient (Api)
  • A substance used in a finished pharmaceutical product intended to furnish pharmacological activity.
  • Antineoplastic Agents
  • Drugs designed to control or kill neoplasms, or tumors.
  • Biologic
  • A drug made from large-molecule living matter, as opposed to small-molecule chemicals.
  • Biologic Drugs
  • Biologic drugs are medicines made from living cells, often used to prevent and treat a variety of illnesses including cancer, autoimmune disorders and infectious diseases.
  • Biosimilar
  • A drug derived from living organisms and marketed after the patent expiration of similar therapies. Also known as flow-on biologics or biogenerics.
  • Biosimilar Drugs
  • Drugs that are almost the same as a biologic drug. Only slight modifications to the "reference product" are required for this classification, without any clinically meaningful differences.
  • Blockbuster Drug
  • A drug that generates annual sales of more than $1.0 billion.
  • Patent Cliff
  • The period when numerous patents on blockbuster drugs are set to expire.
  • What Our Customers Say

    Why buy this report?

    The Brand-Name & Generic Pharmaceutical Manufacturing in Ontario market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Brand-Name & Generic Pharmaceutical Manufacturing in Ontario:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Brand-Name & Generic Pharmaceutical Manufacturing in Ontario market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Brand-Name & Generic Pharmaceutical Manufacturing in Ontario, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.

    clear